November 21, 2014
Astellas Pharma and UCB Japan on November 19 announced that a subgroup analysis of C-OPERA, a Japanese PIII study of the rheumatoid arthritis (RA) treatment certolizumab pegol (CZP; brand name in Japan Cimzia) in early RA patients, confirmed the drug’s...read more